Follow
Yasmin Nasser
Yasmin Nasser
Verified email at ucalgary.ca
Title
Cited by
Cited by
Year
Histamine receptor H1–mediated sensitization of TRPV1 mediates visceral hypersensitivity and symptoms in patients with irritable bowel syndrome
MM Wouters, D Balemans, S Van Wanrooy, J Dooley, V Cibert-Goton, ...
Gastroenterology 150 (4), 875-887. e9, 2016
3922016
Enteric glia
A Rühl, Y Nasser, KA Sharkey
Neurogastroenterology & Motility 16, 44-49, 2004
1622004
Role of enteric glia in intestinal physiology: effects of the gliotoxin fluorocitrate on motor and secretory function
Y Nasser, E Fernandez, CM Keenan, W Ho, LD Oland, LA Tibbles, ...
American Journal of Physiology-Gastrointestinal and Liver Physiology 291 (5 …, 2006
1532006
Prevalence and risk factors for fatigue in adults with inflammatory bowel disease: A systematic review with meta-analysis
A D’Silva, DE Fox, Y Nasser, JK Vallance, RR Quinn, PE Ronksley, ...
Clinical Gastroenterology and Hepatology 20 (5), 995-1009. e7, 2022
972022
Distribution of adrenergic receptors in the enteric nervous system of the guinea pig, mouse, and rat
Y Nasser, W Ho, KA Sharkey
Journal of Comparative Neurology 495 (5), 529-553, 2006
912006
Vasoactive intestinal polypeptide promotes intestinal barrier homeostasis and protection against colitis in mice
X Wu, VS Conlin, V Morampudi, NR Ryz, Y Nasser, G Bhinder, ...
PloS one 10 (5), e0125225, 2015
762015
Perturbed mitochondrial dynamics is a novel feature of colitis that can be targeted to lessen disease
NL Mancini, L Goudie, W Xu, R Sabouny, S Rajeev, A Wang, N Esquerre, ...
Cellular and Molecular Gastroenterology and Hepatology 10 (2), 287-307, 2020
682020
Epidemiologic burden and treatment of chronic symptomatic functional bowel disorders in the United States: a nationwide analysis
C Ma, SE Congly, KL Novak, PJ Belletrutti, M Raman, M Woo, ...
Gastroenterology 160 (1), 88-98. e4, 2021
642021
Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome
Y Nasser, GE Boeckxstaens, MM Wouters, M Schemann, S Vanner
Neurogastroenterology & Motility 26 (4), 455-469, 2014
642014
Yoga as a therapy for irritable bowel syndrome
A D’Silva, G MacQueen, Y Nasser, LM Taylor, JK Vallance, M Raman
Digestive diseases and sciences 65, 2503-2514, 2020
612020
Colitis-induced microbial perturbation promotes postinflammatory visceral hypersensitivity
N Esquerre, L Basso, M Defaye, FA Vicentini, N Cluny, D Bihan, SA Hirota, ...
Cellular and molecular gastroenterology and hepatology 10 (2), 225-244, 2020
582020
Expression of a functional metabotropic glutamate receptor 5 on enteric glia is altered in states of inflammation
Y Nasser, CM Keenan, AC Ma, DM McCafferty, KA Sharkey
Glia 55 (8), 859-872, 2007
522007
Prucalopride in diabetic and connective tissue disease‐related gastroparesis: randomized placebo‐controlled crossover pilot trial
CN Andrews, M Woo, M Buresi, M Curley, M Gupta, J Tack, L Wilsack, ...
Neurogastroenterology & Motility 33 (1), e13958, 2021
482021
Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation
M Bashashati, Y Nasser, CM Keenan, W Ho, F Piscitelli, M Nalli, K Mackie, ...
British journal of pharmacology 172 (12), 3099-3111, 2015
462015
Meditation and Yoga for Irritable Bowel Syndrome: A Randomized Clinical Trial
A D'Silva, DA Marshall, JK Vallance, Y Nasser, V Rajagopalan, ...
The American Journal of Gastroenterology 118 (2), 329, 2023
392023
Stress activates pronociceptive endogenous opioid signalling in DRG neurons during chronic colitis
R Guerrero-Alba, EE Valdez-Morales, NN Jimenez-Vargas, ...
Gut 66 (12), 2121-2131, 2017
372017
Neuromuscular changes in a rat model of colitis
M Aulí, Y Nasser, W Ho, JF Burgueño, CM Keenan, C Romero, ...
Autonomic Neuroscience 141 (1-2), 10-21, 2008
312008
Esophagogastric junction outflow obstruction on manometry: outcomes and lack of benefit from CT and EUS
A Liu, M Woo, Y Nasser, M Gupta, MC Buresi, M Curley, DY Li, L Wilsack, ...
Neurogastroenterology & Motility 31 (12), e13712, 2019
302019
Activation of peripheral blood CD4+ T-cells in IBS is not associated with gastrointestinal or psychological symptoms
Y Nasser, C Petes, C Simmers, L Basso, C Altier, K Gee, SJ Vanner
Scientific reports 9 (1), 3710, 2019
272019
Cannabinoid hyperemesis syndrome in North America: evaluation of health burden and treatment prevalence
CN Andrews, R Rehak, M Woo, I Walker, C Ma, N Forbes, K Rittenbach, ...
Alimentary Pharmacology & Therapeutics 56 (11-12), 1532-1542, 2022
242022
The system can't perform the operation now. Try again later.
Articles 1–20